RME

Myriad Reports on Historic Drilling at Copper Mountain

Retrieved on: 
Tuesday, March 5, 2024

Earlier interpretations of the mineralization at Copper Mountain show that the controls on mineralization were not fully understood.

Key Points: 
  • Earlier interpretations of the mineralization at Copper Mountain show that the controls on mineralization were not fully understood.
  • The location of the Copper Mountain uranium district in relation to other uranium districts in Wyoming is shown in Figure 1 below.
  • To view an enhanced version of this graphic, please visit:
    The grade intervals were calculated as weighted averages using 3-foot composite grades that Anaconda derived from drilling data acquired from RME which conducted uranium exploration in the Copper Mountain area between 1969 to 1982.
  • Myriad plans to conduct a site visit to Copper Mountain at the earliest possibility that weather conditions will allow, possibly late April to early May, 2024.

Tynt Technologies Closes 2023 with Successful Seed Round, Partnerships, and Growth

Retrieved on: 
Thursday, January 25, 2024

BOULDER, Colo., Jan. 25, 2024 /PRNewswire-PRWeb/ -- Tynt Technologies, Inc., the developer of the first-ever blackout dynamic ultra-energy-efficient window, enters 2024 on the heels of a year full of significant growth underscored by a successful seed round, world-class partnerships, breakthrough technology developments, and leadership additions.

Key Points: 
  • In 2023, Tynt closed a $7.1 million Seed II led by KOMPAS.
  • Showcased at the NREL Industry Growth Forum, this was the first time a full blackout dynamic window has been shown.
  • "Last year was a serious turning point for Tynt Technologies," said Ameen K. Saafir , CEO and co-founder of Tynt.
  • "This is an incredibly exciting time to join Tynt Technologies," said Crystal Petersen, VP of Business Development.

The Barnes Global Advisors Recognized as a Finalist for the 2024 MilAM/America Makes Education and Workforce Development Award

Retrieved on: 
Wednesday, January 17, 2024

SEWICKLEY, Pa., Jan. 17, 2024 /PRNewswire-PRWeb/ -- The Barnes Global Advisors (TBGA) were recognized at the Military AM Summit as a finalist for the 2024 Education and Workforce Development Award, presented in partnership with America Makes. This recognition is a testament to TBGA's commitment to advancing additive manufacturing (AM) technologies and fostering a skilled workforce in the United States.

Key Points: 
  • SEWICKLEY, Pa., Jan. 17, 2024 /PRNewswire-PRWeb/ -- The Barnes Global Advisors (TBGA) were recognized at the Military AM Summit as a finalist for the 2024 Education and Workforce Development Award, presented in partnership with America Makes.
  • We're proud that our training efforts were acknowledged as we consider workforce development to be a pillar of our organization.
  • We're proud that our training efforts were acknowledged as we consider workforce development to be a pillar of our organization."
  • Learn more about The Barnes Global Advisors and the Resilient Manufacturing Ecosystem by visiting the website at: http://www.barnesglobaladvisors.com
    View original content to download multimedia: https://www.prweb.com/releases/the-barnes-global-advisors-recognized-as-...

Argus launches daily German HVO prices

Retrieved on: 
Wednesday, January 17, 2024

HAMBURG, Germany, Jan. 17, 2024 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has launched daily prices for German hydrotreated vegetable oil (HVO), bringing new price transparency to the physical supply chain of rates at the point of truck loading in Europe's biggest energy market.

Key Points: 
  • The prices are for HVO truck sales including energy tax and the value of greenhouse gas (GHG) emissions savings.
  • The German market for HVO is growing rapidly and further acceleration is expected in 2024, when the government is scheduled to permit unrestricted HVO sales at filling stations.
  • Our new German HVO prices have been launched in response to feedback from market participants across the industry and bring much needed transparency to this rapidly growing market.
  • Argus' new assessments for HVO in Germany join a suite of hydroprocessed biofuels prices including four classes of Argus wholesale HVO fob ARA prices, in addition to prices for Asian HVO and US renewable diesel.

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer

Retrieved on: 
Wednesday, November 1, 2023

CAMBRIDGE, England, Nov. 1, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce the appointment of Marguerite Hutchinson, J.D., as Chief Business Officer.

Key Points: 
  • CAMBRIDGE, England, Nov. 1, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce the appointment of Marguerite Hutchinson, J.D., as Chief Business Officer.
  • Jerry McMahon, Chief Executive Officer of STORM Therapeutics, said: "We are excited by the addition of Marguerite to the STORM leadership team as we continue to maximise collaborations for our developing pipeline of products targeting RNA modifying enzymes.
  • Marguerite joins STORM from Tatara Therapeutics, where she was Chief Executive Officer, a UCSF spin-out which she set up and raised seed financing.
  • Prior to this, Marguerite was Chief Business Officer at Frontier Medicines Corporation where she oversaw and led all business development activities including a collaboration with AbbVie.

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer

Retrieved on: 
Wednesday, November 1, 2023

CAMBRIDGE, England, Nov. 1, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce the appointment of Marguerite Hutchinson, J.D., as Chief Business Officer.

Key Points: 
  • CAMBRIDGE, England, Nov. 1, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce the appointment of Marguerite Hutchinson, J.D., as Chief Business Officer.
  • Jerry McMahon, Chief Executive Officer of STORM Therapeutics, said: "We are excited by the addition of Marguerite to the STORM leadership team as we continue to maximise collaborations for our developing pipeline of products targeting RNA modifying enzymes.
  • Marguerite joins STORM from Tatara Therapeutics, where she was Chief Executive Officer, a UCSF spin-out which she set up and raised seed financing.
  • Prior to this, Marguerite was Chief Business Officer at Frontier Medicines Corporation where she oversaw and led all business development activities including a collaboration with AbbVie.

Showtime Sound, LLC adds L-Acoustics' new L-ISA Technology for Immersive Hyperreal Sound Experiences

Retrieved on: 
Thursday, August 24, 2023

Over the years, Showtime's partnership with L-Acoustics has proven to be a sound investment. As detailed by Marc Chauvin, Showtime's Director of Technical Operations, "In looking at our industry position, we have always been proactive about our partnerships. By being a part of the L-Acoustics provider family, we are able to leverage our experience and expertise in conjunction with the reputation and quality that L-Acoustics affords us and our clients. The support and dedication that we find from L-Acoustics as a whole, and in particular Sales Manager Jon McGarry, goes well beyond a vendor/client relationship. It is one of a complete understanding of what we need, what they can provide, and how we can all work together to elevate the client experience. Very few companies have a level of support that we are shown day in and day out, such as in the middle of the night on a Saturday, or on a holiday, or even in the random phone/email correspondences to check in -- unrelated to sales." This level of commitment has shown L-Acoustics to be an unrivaled industry connection.

Key Points: 
  • From hometown festivals to world tours, Showtime has since been working with L-Acoustics gear for well over a decade.
  • As explained by L-Acoustics, "L-ISA technology enables artists to create and deliver immersive sound for live and recorded productions of any scale.
  • Showtime Director of Operations and Production Brian Linnemann explained why adding L-ISA technology was a good move for Showtime, "L-ISA technology fits into two different segments of our business.
  • With this investment, Showtime continues to partner with L-Acoustics, now utilizing spatial audio to create immersive hyperreal experiences."

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

Retrieved on: 
Tuesday, August 8, 2023

CAMBRIDGE, England, Aug. 8, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce that it has published a scientific manuscript in the internationally recognised scientific journal Cancer Discovery.

Key Points: 
  • Using pre-clinical cancer models, the study shows that pharmacological inhibition of METTL3 induces double-stranded RNA formation and a profound cell-intrinsic interferon response that potentiates T-cell killing of cancer cells.
  • Oliver Rausch, Chief Scientific Officer of STORM Therapeutics and joint senior author of the study, said, "We are pleased to share this new data with the scientific community.
  • Our study identifies a novel therapeutic mechanism triggered by METTL3 inhibition that opens a significant opportunity for METTL3 inhibitors in immuno-oncology.
  • Andrew A Guirguis, Yaara Ofir-Rosenfeld et al, 2023, Cancer Discovery (advanced online publication) https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.C...

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

Retrieved on: 
Tuesday, August 8, 2023

CAMBRIDGE, England, Aug. 8, 2023 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce that it has published a scientific manuscript in the internationally recognised scientific journal Cancer Discovery.

Key Points: 
  • Using pre-clinical cancer models, the study shows that pharmacological inhibition of METTL3 induces double-stranded RNA formation and a profound cell-intrinsic interferon response that potentiates T-cell killing of cancer cells.
  • Oliver Rausch, Chief Scientific Officer of STORM Therapeutics and joint senior author of the study, said, "We are pleased to share this new data with the scientific community.
  • Our study identifies a novel therapeutic mechanism triggered by METTL3 inhibition that opens a significant opportunity for METTL3 inhibitors in immuno-oncology.
  • Andrew A Guirguis, Yaara Ofir-Rosenfeld et al, 2023, Cancer Discovery (advanced online publication) https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.C...

Argus launches Asia-Pacific biofuels on its price discovery platform

Retrieved on: 
Wednesday, March 22, 2023

SINGAPORE, March 22, 2023 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has extended its Argus Open Markets (AOM) real-time electronic price discovery platform to include used cooking oil (UCO) and used cooking oil methyl ester (UCOME) prices in Asia-Pacific.

Key Points: 
  • SINGAPORE, March 22, 2023 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has extended its Argus Open Markets (AOM) real-time electronic price discovery platform to include used cooking oil (UCO) and used cooking oil methyl ester (UCOME) prices in Asia-Pacific.
  • The Asia-Pacific UCO and UCOME markets are growing quickly as stricter emissions reduction targets around the world drive rising demand for renewable feedstocks and fuels.
  • Argus Media chairman and chief executive Adrian Binks said: "The Asia-Pacific region is a huge source of growth of biofuel production, consumption and trading.
  • We have worked closely with the industry to launch Argus Open Markets, which enables efficient and transparent price discovery and will help the biofuels market develop and fulfil its important role in the energy transition."